BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

726 related articles for article (PubMed ID: 25547956)

  • 1. [The revolution of monoclonal antibodies in the treatment of thrombotic microangiopathy].
    Sauvètre G; Grange S; Froissart A; Veyradier A; Coppo P; Benhamou Y
    Rev Med Interne; 2015 May; 36(5):328-38. PubMed ID: 25547956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombotic microangiopathies.
    Rosove MH
    Semin Arthritis Rheum; 2014 Jun; 43(6):797-805. PubMed ID: 24360024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring.
    Mannucci PM; Cugno M
    Thromb Res; 2015 Nov; 136(5):851-4. PubMed ID: 26386489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Atypical hemolytic uremic syndrome (aHUS): new insights into pathogenesis leading to novel therapeutic approaches].
    Kistler AD
    Praxis (Bern 1994); 2016 Mar; 105(7):389-96. PubMed ID: 27005733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathology Consultation on the Diagnosis and Treatment of Thrombotic Microangiopathies (TMAs).
    Williams LA; Marques MB;
    Am J Clin Pathol; 2016 Feb; 145(2):158-65. PubMed ID: 27124904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syndromes of Thrombotic Microangiopathy.
    Shatzel JJ; Taylor JA
    Med Clin North Am; 2017 Mar; 101(2):395-415. PubMed ID: 28189178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand.
    Fox LC; Cohney SJ; Kausman JY; Shortt J; Hughes PD; Wood EM; Isbel NM; de Malmanche T; Durkan A; Hissaria P; Blombery P; Barbour TD
    Nephrology (Carlton); 2018 Jun; 23(6):507-517. PubMed ID: 29419916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemolytic and uremic syndrome and related thrombotic microangiopathies: Epidemiology, pathophysiology and clinics].
    Rafat C; Coppo P; Fakhouri F; Frémeaux-Bacchi V; Loirat C; Zuber J; Rondeau E
    Rev Med Interne; 2017 Dec; 38(12):817-824. PubMed ID: 28711159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic-therapeutic algorithm for thrombotic microangiopathy. A report of two cases.
    Rubio-Haro R; Quesada-Carrascosa M; Hernández-Laforet J; Ferrer Gómez C; De Andrés J
    Rev Esp Anestesiol Reanim (Engl Ed); 2022 Mar; 69(3):179-182. PubMed ID: 35283062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The frontline of TMA management].
    Saito K; Matsumoto M
    Rinsho Ketsueki; 2022; 63(5):463-470. PubMed ID: 35662172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and treatment of microangiopathic hemolytic anemia].
    Morishita E
    Rinsho Ketsueki; 2015 Jul; 56(7):795-806. PubMed ID: 26251142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange.
    Clark WF
    Semin Dial; 2012; 25(2):214-9. PubMed ID: 22309967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [TTP and aHUS: new insights].
    Miyakawa Y
    Rinsho Ketsueki; 2017; 58(5):530-536. PubMed ID: 28592771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
    Wada H; Matsumoto T; Yamashita Y
    Semin Thromb Hemost; 2014 Nov; 40(8):866-73. PubMed ID: 25377323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [CME: Diagnostic Approach and Management of Thrombotic Microangiopathy].
    Sutter T; Fehr T; Venzin R
    Praxis (Bern 1994); 2022; 111(14):771-777. PubMed ID: 36285415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of patients with microangiopathic hemolytic anemia and thrombocytopenia.
    George JN; Charania RS
    Semin Thromb Hemost; 2013 Mar; 39(2):153-60. PubMed ID: 23390027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy-related thrombotic microangiopathies: Clues from complement biology.
    Fakhouri F
    Transfus Apher Sci; 2016 Apr; 54(2):199-202. PubMed ID: 27158062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome.
    Scully M; Goodship T
    Br J Haematol; 2014 Mar; 164(6):759-66. PubMed ID: 24387053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics.
    Saha M; McDaniel JK; Zheng XL
    J Thromb Haemost; 2017 Oct; 15(10):1889-1900. PubMed ID: 28662310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombotic Microangiopathy Syndromes-Common Ground and Distinct Frontiers.
    Hanna RM; Henriksen K; Kalantar-Zadeh K; Ferrey A; Burwick R; Jhaveri KD
    Adv Chronic Kidney Dis; 2022 Mar; 29(2):149-160.e1. PubMed ID: 35817522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.